Adriane Oliveira

Adriane Oliveira

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
Adriane OliveiraAdriane Oliveira
Adriane Oliveira
LRLara Da mata Aredes Riguetti
Lara Da mata Aredes Riguetti
BPBernardo A. S. Pereira
Bernardo A. S. Pereira
Carlos Roberto AlvesCarlos Roberto Alves
Carlos Roberto Alves
FSFranklin Souza Silva
Franklin Souza Silva
Degrons are short peptide sequences that signalize target sites for protein degradation by proteases. Herein, we bring forth the discussion on degrons present in proteins related to the immune system of Mus musculus that are potential targets for cysteine and serine proteases of Leishmania spp. and their possible roles on host immune regulation by parasites. The Merops database was used to identify protease substrates and proteases sequence motifs, while MAST/MEME Suite was applied to find degron motifs in murine cytokines (IFN-y, IL-4, IL-5, IL-13, IL-17) and transcription factors (NF-kappaB, STAT-1, AP-1, CREB, and BACH2). STRING tool was used to construct an interaction network for the immune factors and SWISS-MODEL server to generate three-dimensional models of proteins. In silico assays confirm the occurrence of degrons in the selected immune response factors. Further analyses were conducted only in those with resolved three-dimensional structures. The predicted interaction network of degron-containing M. musculus proteins shows the possibility that the specific activity of parasite proteases could interfere with the trend of Th1/Th2 immune responses. Data suggest that degrons may play a role in the immune responses in leishmaniases as targets for parasite proteases activity, directing the degradation of specific immune-related factors.

10 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
JPJuliana Peixoto
Juliana Peixoto
Adriane OliveiraAdriane Oliveira
Adriane Oliveira
PMPatrícia Queiroz Monteiro
Patrícia Queiroz Monteiro
LGLuiz Filipe Gonçalves-Oliveira
Luiz Filipe Gonçalves-Oliveira
VAValter Viana Andrade-Neto
Valter Viana Andrade-Neto
Carlos Roberto AlvesCarlos Roberto Alves
Carlos Roberto Alves
Epoxy-α-lapachone (Lap) and Epoxymethyl-lawsone (Law) are oxiranes derived from Lapachol and have been shown to be promising drugs for Leishmaniases treatment. Although, it is known the action spectrum of both compounds affect the Leishmania spp. multiplication, there are gaps in the molecular binding details of target enzymes related to the parasite’s physiology. Molecular docking assays simulations were performed using DockThor server to predict the preferred orientation of both compounds to form stable complexes with key enzymes of metabolic pathway, electron transport chain, and lipids metabolism of Leishmania spp. This study showed the hit rates of both compounds interacting with lanosterol C-14 demethylase (−8.4 kcal/mol to −7.4 kcal/mol), cytochrome c (−10.2 kcal/mol to −8.8 kcal/mol), and glyceraldehyde-3-phosphate dehydrogenase (−8.5 kcal/mol to −7.5 kcal/mol) according to Leishmania spp. and assessed compounds. The set of molecular evidence reinforces the potential of both compounds as multi-target drugs for interrupt the network interactions between parasite enzymes, which can lead to a better efficacy of drugs for the treatment of leishmaniases.